MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-12-2026
Repro Med Systems Operating Cash Flow 2011-2026 | KRMD
Annual Operating Cash Flow Repro Med Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 462 K | -320 K | -4.89 M | -5.4 M | -4.32 M | -743 K | 321 K | 1.48 M | 900 K | - | 826 K | 954 K | 785 K | 561 K | 1.03 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.48 M | -5.4 M | -597 K |
Quarterly Operating Cash Flow Repro Med Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -237 K | - | - | - | -347 K | - | - | - | -4.66 M | - | -6.74 M | - | -1.75 M | - | -3.6 M | - | -2.61 M | - | 968 K | 2.71 M | 153 K | - | -502 K | -1.48 M | -1.05 M | - | 1.35 M | 956 K | -13.1 K | - | 497 K | -271 K | 143 K | - | -213 K | - | - | - | - | 11.1 K | - | - | - | 220 K | - | - | 599 K | 498 K | - | - | 504 K | 377 K | - | - | 258 K | 172 K | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.71 M | -6.74 M | -502 K |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
845 M | $ 16.55 | -0.63 % | $ 8.49 B |  USA |
 |
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M | USA |
 |
Alcon
ALC
|
1.34 B | $ 74.08 | -0.76 % | $ 40.4 B |  Schweiz |
 |
The Cooper Companies
COO
|
796 M | $ 68.85 | -2.06 % | $ 13.7 B | USA |
 |
electroCore
ECOR
|
-8.19 M | $ 6.76 | -4.05 % | $ 57.3 K | USA |
 |
Ekso Bionics Holdings
EKSO
|
-11.8 M | $ 9.14 | -6.26 % | $ 22.2 M | USA |
 |
BioLife Solutions
BLFS
|
8.43 M | $ 18.62 | -3.37 % | $ 858 M | USA |
 |
Glaukos Corporation
GKOS
|
-57.8 M | $ 116.32 | -0.36 % | $ 5.63 B | USA |
 |
AtriCure
ATRC
|
57.3 M | $ 29.09 | -0.34 % | $ 1.39 B | USA |
 |
Haemonetics Corporation
HAE
|
182 M | $ 59.06 | 1.1 % | $ 2.97 B | USA |
 |
Harvard Bioscience
HBIO
|
6.73 M | $ 5.31 | -3.95 % | $ 236 M | USA |
 |
iRhythm Technologies
IRTC
|
80.9 M | $ 116.43 | -0.68 % | $ 3.73 B | USA |
 |
Masimo Corporation
MASI
|
196 M | $ 178.36 | -0.07 % | $ 9.51 B | USA |
 |
Microbot Medical
MBOT
|
-13 M | $ 2.29 | -2.97 % | $ 105 M |  Israel |
 |
Milestone Scientific
MLSS
|
-2.92 M | $ 0.29 | 1.38 % | $ 23.8 M | USA |
 |
Envista Holdings Corporation
NVST
|
276 M | $ 24.99 | -3.21 % | $ 4.2 B | USA |
 |
Pro-Dex
PDEX
|
-1.68 M | $ 50.03 | 3.09 % | $ 164 M | USA |
 |
ResMed
RMD
|
351 M | $ 223.41 | -0.62 % | $ 32.6 B | USA |
 |
ICU Medical
ICUI
|
180 M | $ 121.46 | -1.24 % | $ 2.99 B | USA |
 |
Retractable Technologies
RVP
|
-7.06 M | $ 0.72 | 1.45 % | $ 21.6 M | USA |
 |
InfuSystem Holdings
INFU
|
17.5 M | $ 9.41 | -0.21 % | $ 194 M | USA |
 |
Isoray
ISR
|
-82.5 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
3.03 B | $ 450.18 | -0.53 % | $ 161 B | USA |
 |
STAAR Surgical Company
STAA
|
-34.2 M | $ 21.38 | 2.0 % | $ 1.06 B | USA |
 |
Stereotaxis
STXS
|
-13.7 M | $ 1.86 | -1.59 % | $ 169 M | USA |
 |
LeMaitre Vascular
LMAT
|
81.3 M | $ 109.87 | 0.65 % | $ 2.49 B | USA |
 |
Merit Medical Systems
MMSI
|
297 M | $ 68.33 | 0.77 % | $ 4.04 B | USA |
 |
Utah Medical Products
UTMD
|
14.7 M | $ 63.75 | 1.3 % | $ 207 M | USA |
 |
Predictive Oncology
POAI
|
-12.4 M | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
-54.1 M | $ 19.27 | -16.0 % | $ 1.3 B | USA |
 |
West Pharmaceutical Services
WST
|
755 M | $ 257.61 | 0.25 % | $ 18.6 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
235 M | $ 11.46 | -1.55 % | $ 2.29 B | USA |
 |
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | USA |
 |
STERIS plc
STE
|
1.15 B | $ 218.23 | -0.8 % | $ 21.5 B | USA |
 |
AngioDynamics
ANGO
|
-10.1 M | $ 9.44 | -4.07 % | $ 386 M | USA |
 |
Becton, Dickinson and Company
BDX
|
3.33 B | $ 154.93 | -0.2 % | $ 44.6 B | USA |
 |
Nephros
NEPH
|
827 K | $ 2.73 | -4.55 % | $ 28.4 M | USA |
 |
OraSure Technologies
OSUR
|
-49 M | $ 3.03 | -1.79 % | $ 223 M | USA |
 |
Repligen Corporation
RGEN
|
114 M | $ 114.82 | -1.82 % | $ 6.4 M | USA |